The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post-Hoc Analysis of ACCELERATE.

dc.contributor.author	Shah, Nishant P
dc.contributor.author	Wang, Qiuqing
dc.contributor.author	Wolski, Katherine E
dc.contributor.author	Cho, Leslie
dc.contributor.author	McErlean, Ellen
dc.contributor.author	Ruotolo, Giacomo
dc.contributor.author	Weerakkody, Govinda
dc.contributor.author	Riesmeyer, Jeffrey S
dc.contributor.author	Nicholls, Stephen J
dc.contributor.author	Lincoff, A Michael
dc.contributor.author	Nissen, Steven E
dc.contributor.author	Menon, Venu
dc.date.accessioned	2019-12-27T15:52:54Z
dc.date.available	2019-12-27T15:52:54Z
dc.date.issued	2019-12-05
dc.date.updated	2019-12-27T15:52:53Z
dc.identifier	dc19-1117
dc.identifier.issn	0149-5992
dc.identifier.issn	1935-5548
dc.identifier.uri	https://hdl.handle.net/10161/19656
dc.language	eng
dc.publisher	American Diabetes Association
dc.relation.ispartof	Diabetes care
dc.relation.isversionof	10.2337/dc19-1117
dc.title	The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post-Hoc Analysis of ACCELERATE.
dc.type	Journal article
duke.contributor.orcid	Shah, Nishant P\|0000-0002-2666-7132
pubs.begin-page	dc191117
pubs.end-page	dc191117
pubs.organisational-group	School of Medicine
pubs.organisational-group	Duke
pubs.organisational-group	Medicine, Cardiology
pubs.organisational-group	Medicine
pubs.organisational-group	Clinical Science Departments
pubs.publication-status	Published

Files

Now showing 1 - 1 of 1